Patients suffering from type 1 or type 2 diabetes can now rest assure or rather breath easily because a new cure for low blood sugar has been discovered. Nasal spray showed promising results in diabetic patients, and it is far more effective against keeping blood sugar levels at bay, than any other solution.
The clinical trials and the project have both been funded by Locemia Solution, the pharmaceutical giant who came up with the novel nasal spray. According to the paper detailing this novel treatment, it would seem that the spray contains large doses of powdered glucagon.
Glucagon is a compound widely used in treating the symptoms associated with low blood sugar, or hypoglycemia. The therapy employing powdered glucagon was approved by the Food and Drug Administration some time ago and since then the solution has been used to effectively treat hypoglycemia cases.
According to several medical specialists, in order to use the solution, one must mix the powdered glucagon with water or plain blood serum in order to create the hypoglycemic solution. After that, the resulting serum would be injected into the patient’s muscles.
The powdered glucagon solution is very effective in treating patients with low blood sugar, especially when they feel dizzy or they fall into a unconscious state.
According to several key studies in this area, powdered glucagon is very effective when it comes to increasing the levels of blood sugar. But it would seem that the king treatment might have met his match with this new, to go solution.
The goal of the study was to find out which of the two methods is more effective at getting those blood sugar levels up. In order to verify the validity of their claims, the medical examiners enrolled several volunteers in a clinical trial.
Approximately 75 patients suffering from type 1 diabetes have taken part in this new clinical trial. Nearly one-third of the patients participating in this clinical trial accused nausea and other symptoms related to low blood sugar levels.
Each of them received a daily dose of this new treatment. Initial results have determined that their condition improved after using this new treatment. However, during the trial any patients accused discomforts in the head and face area.
But, all and all, the treatment seems to be very effective at treating the symptoms associated with hypoglycemia. Moreover, the drug has little to no side-effects, and none of the patients who have received this novel treatment has displayed any reaction to the drug.